Identification the Expression of Sox2 in Colorectal Cancer Tissues

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Lixiao Xu, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01589900
First received: April 30, 2012
Last updated: May 2, 2012
Last verified: May 2012
  Purpose

Sox2 has been studied in several types of human solid tumors. The investigators found that Sox2 had higher expression level in colorectal cancer and metastatic tissues than normal tissues. So the investigators assumed that whether Sox2 plays an important role in the progression and migration of colon cancer.


Condition
Colorectal Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Role of Sox2 in Tumor Genesis and Migration in Colorectal Cancer

Resource links provided by NLM:


Further study details as provided by Sun Yat-sen University:

Enrollment: 136
Study Start Date: January 2005
Study Completion Date: March 2012
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Detailed Description:

In our study, we examined Sox2 expression in archived human colon cancer tissues and found that its Sox2 expression correlates with reduced patient survival, increased tumor grade and metastasis probability.

  Eligibility

Ages Eligible for Study:   24 Years to 79 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All rchived 136 tissues were obtained and pathologically confirmed from patients who underwent surgical resections between 2005 and 2006 at the Cancer Center of Sun Yat-sen University (Guangzhou, Guangdong, P. R. China)). The patients from whom the samples were derived underwent curative resection between 2005 and 2006. Tumor differentiation was characterized according to WHO classification, while the surgical pathologic stage was analyzed according to the TNM classification system of the International Union against Cancer. All samples were anonymously coded in accordance with local ethical guidelines.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of colorectal cancer

Exclusion Criteria:

  • Clinical diagnosis characteristics not exactly described in the patients information
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01589900

Sponsors and Collaborators
Sun Yat-sen University
Investigators
Principal Investigator: Yan Zhang, M.D.Ph.D Laboratory of Cancer and Stem Cell Biology School of Life Sciences Sun Yat-sen University
  More Information

Additional Information:
No publications provided

Responsible Party: Lixiao Xu, Laboratory of Cancer and Stem Cell Biology, Sun Yat-sen University
ClinicalTrials.gov Identifier: NCT01589900     History of Changes
Other Study ID Numbers: SYSU
Study First Received: April 30, 2012
Last Updated: May 2, 2012
Health Authority: China: Ministry of Science and Technology

Keywords provided by Sun Yat-sen University:
colorectal cancer
invasion
metastasis
IHC

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on August 19, 2014